Creative Medical Technology Holdings, Inc. (CELZ) stock
CELZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.62−0.01 (-2.08%)
Close on Nov 12, 2026Market cap $4.06MP/E –Yield –
Creative Medical Technology operating margin
Operating margin is operating income as a percentage of revenue.
Creative Medical Technology's operating margin for the twelve months ending Sep 30, 2026 was -256435.0%. For fiscal 2025 it was -102380.2%, against -52216.9% the year before. The highest annual figure on record is -677.7% in fiscal 2020.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -102380.2% | −50163.3 |
| FY2024 | Dec 31, 2024 | -52216.9% | +10229.0 |
| FY2023 | Dec 31, 2023 | -62445.9% | −50883.4 |
| FY2022 | Dec 31, 2022 | -11562.5% | −8000.3 |
| FY2021 | Dec 31, 2021 | -3562.2% | −2884.5 |
| FY2020 | Dec 31, 2020 | -677.7% | +5.2 |
| FY2019 | Dec 31, 2019 | -682.9% | +212.8 |
| FY2018 | Dec 31, 2018 | -895.7% | +23641.9 |
| FY2017 | Dec 31, 2017 | -24537.6% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -64859.4% | −5798.1 |
| Q1 FY2025 | Mar 31, 2025 | -55349.3% | −29629.5 |
| Q4 FY2024 | Dec 31, 2024 | -62857.8% | −29105.5 |
| Q2 FY2024 | Jun 30, 2024 | -20316.3% | −18461.0 |
| Q4 FY2023 | Dec 31, 2023 | -59061.3% | −51362.2 |
| Q3 FY2023 | Sep 30, 2023 | -25719.8% | −23546.1 |
| Q4 FY2022 | Dec 31, 2022 | -33752.3% | −25418.0 |
| Q3 FY2022 | Sep 30, 2022 | -1855.3% | +3303.1 |
| Q1 FY2022 | Mar 31, 2022 | -7699.1% | −5853.0 |
| Q4 FY2021 | Dec 31, 2021 | -2173.6% | −1858.7 |
| Q3 FY2021 | Sep 30, 2021 | -8334.4% | −7566.4 |
| Q2 FY2021 | Jun 30, 2021 | -5158.4% | −4362.6 |
| Q4 FY2020 | Dec 31, 2020 | -1846.1% | −1370.6 |
| Q3 FY2020 | Sep 30, 2020 | -314.9% | +132.3 |
| Q2 FY2020 | Jun 30, 2020 | -768.0% | −274.5 |
| Q1 FY2020 | Mar 31, 2020 | -795.8% | −239.7 |
| Q3 FY2019 | Sep 30, 2019 | -475.5% | +49.0 |
| Q2 FY2019 | Jun 30, 2019 | -447.2% | +6111.8 |
| Q1 FY2019 | Mar 31, 2019 | -493.5% | +1633.7 |
| Q4 FY2018 | Dec 31, 2018 | -556.2% | +4568.2 |
| Q3 FY2018 | Sep 30, 2018 | -524.5% | – |
| Q2 FY2018 | Jun 30, 2018 | -6559.0% | – |
| Q1 FY2018 | Mar 31, 2018 | -2127.3% | – |
| Q4 FY2017 | Dec 31, 2017 | -5124.4% | – |
See a number that looks wrong?